Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2009 4
2010 7
2011 10
2012 3
2013 10
2014 7
2015 7
2016 8
2017 7
2018 4
2019 6
2020 5
2021 4
2022 2
2023 5
2024 6
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
The effect of pelvic floor muscle training in men with benign prostatic hyperplasia and overactive bladder.
Hagovska M, Svihra J Sr, Macko L, Breza J Jr, Svihra J Jr, Luptak J, Lachvac L. Hagovska M, et al. World J Urol. 2024 May 2;42(1):287. doi: 10.1007/s00345-024-04974-7. World J Urol. 2024. PMID: 38698269 Free PMC article. Clinical Trial.
OBJECTIVE: The aim of this study was to evaluate the effect of combining pelvic floor muscle training with the urgency suppression technique (PFMT-st) and silodosin in comparison with silodosin in men with benign prostatic hyperplasia (BPH) and overactive bladder (O …
OBJECTIVE: The aim of this study was to evaluate the effect of combining pelvic floor muscle training with the urgency suppression technique …
Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
Chapple CR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fernández Fernández E; European Silodosin Study Group. Chapple CR, et al. Eur Urol. 2011 Mar;59(3):342-52. doi: 10.1016/j.eururo.2010.10.046. Epub 2010 Nov 10. Eur Urol. 2011. PMID: 21109344 Clinical Trial.
OBJECTIVE: Our aim was to test silodosin's superiority to placebo and noninferiority to tamsulosin and discuss the findings in the context of a comprehensive literature review of the new compound silodosin. ...Of note, only silodosin significantly redu …
OBJECTIVE: Our aim was to test silodosin's superiority to placebo and noninferiority to tamsulosin and discuss the findings in …
Comparative study between silodosin, tamsulosin, silodosin plus tadalafil, and tamsulosin plus tadalafil as a medical expulsive therapy for lower ureteral stones: a prospective randomized trial.
Dogha MM, Sherif IGA, Madney YM, Harb HS, Rabea H. Dogha MM, et al. Int Urol Nephrol. 2025 Jun;57(6):1827-1833. doi: 10.1007/s11255-024-04356-3. Epub 2025 Jan 10. Int Urol Nephrol. 2025. PMID: 39792210 Clinical Trial.
PURPOSE: To examine the safety and efficiency of a single-drug therapy with silodosin or tamsulosin versus combined therapy with silodosin plus tadalafil and tamsulosin plus tadalafil as a medical expulsive therapy (MET) for lower ureteral stones. ...Patients with l …
PURPOSE: To examine the safety and efficiency of a single-drug therapy with silodosin or tamsulosin versus combined therapy with s …
Does preoperative silodosin administration facilitate ureteral dilatation during flexible ureterorenoscopy? A randomized clinical trial.
Diab T, El-Shaer W, Ibrahim S, El-Barky E, Elezz AA. Diab T, et al. Int Urol Nephrol. 2024 Mar;56(3):839-846. doi: 10.1007/s11255-023-03824-6. Epub 2023 Oct 30. Int Urol Nephrol. 2024. PMID: 37902925 Free PMC article. Clinical Trial.
The patients were randomly divided into two equal groups. Group A (silodosin group) included patients in whom F-URS was done with daily preoperative intake of 8 mg silodosin for 1 week and group B (placebo/control group) included patients in whom F-URS was done with …
The patients were randomly divided into two equal groups. Group A (silodosin group) included patients in whom F-URS was done with dai …
[Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe].
Chapple ChR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fernandez Fernandez E. Chapple ChR, et al. Urologiia. 2012 Sep-Oct;(5):38-42, 44-5. Urologiia. 2012. PMID: 23342615 Clinical Trial. Russian.
OBJECTIVE: Our aim was to test silodosin's superiority to placebo and noninferiority to tamsulosin and discuss the findings in the context of a comprehensive literature review of the new compound silodosin. ...Of note, only silodosin significantly redu …
OBJECTIVE: Our aim was to test silodosin's superiority to placebo and noninferiority to tamsulosin and discuss the findings in …
Comparative study between Tamsulosin, Silodosin and Tadalafil as a medical expulsive therapy for lower ureteral stones.
Abdelaal MA, El-Dydamony EM. Abdelaal MA, et al. Arch Ital Urol Androl. 2023 Feb 22;95(1):10849. doi: 10.4081/aiua.2023.10849. Arch Ital Urol Androl. 2023. PMID: 36924384 Free article. Clinical Trial.
OBJECTIVE: To compare the efficacy of Tamsulosin, Silodosin and Tadalafil as a medical expulsive therapy for treatment of distal ureteral calculi. ...Patients in group A received Tamsulosin 0.4mg, in group B received Silodosin, and in group C receive Tadalafil 5 mg. …
OBJECTIVE: To compare the efficacy of Tamsulosin, Silodosin and Tadalafil as a medical expulsive therapy for treatment of distal uret …
Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study.
Hagiwara K, Koie T, Iwamura H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C. Hagiwara K, et al. Biomed Res Int. 2016;2016:4975851. doi: 10.1155/2016/4975851. Epub 2016 Apr 18. Biomed Res Int. 2016. PMID: 27195288 Free PMC article. Clinical Trial.
This study aimed to assess the efficacy of combination therapy with dutasteride and silodosin in patients with acute urinary retention (AUR) caused by benign prostatic hyperplasia (BPH). ...In conclusion, a combination of dutasteride and silodosin therapy may be eff …
This study aimed to assess the efficacy of combination therapy with dutasteride and silodosin in patients with acute urinary retentio …
Role of tamsulosin, tadalafil, and silodosin as the medical expulsive therapy in lower ureteric stone: a randomized trial (a pilot study).
Kumar S, Jayant K, Agrawal MM, Singh SK, Agrawal S, Parmar KM. Kumar S, et al. Urology. 2015 Jan;85(1):59-63. doi: 10.1016/j.urology.2014.09.022. Urology. 2015. PMID: 25530364 Clinical Trial.
MATERIALS AND METHODS: Between January 2011 and December 2012, 285 patients presenting with distal ureteric stones of size 5-10 mm were on consent randomly assigned to 1 of 3 outpatient treatment arms: tamsulosin (group A), silodosin (group B), and tadalafil (group C). The …
MATERIALS AND METHODS: Between January 2011 and December 2012, 285 patients presenting with distal ureteric stones of size 5-10 mm were on c …
Evaluation of the efficacy and safety of either or both mirabegron and silodosin, as a medical expulsive therapy for distal ureteric stones.
Abdel-Kader MS, Sayed AM, Sayed SM, AbdelRazek M. Abdel-Kader MS, et al. Int Urol Nephrol. 2024 May;56(5):1605-1610. doi: 10.1007/s11255-023-03880-y. Epub 2023 Dec 2. Int Urol Nephrol. 2024. PMID: 38041752 Free PMC article. Clinical Trial.

Anejaculation occurred at a significantly higher rate in the silodosin group (73.9%) and combination group (84%) compared to the mirabegron group (P < 0.05). CONCLUSIONS: The findings of this study suggest that both silodosin and mirabegron are effective treatmen

…
Anejaculation occurred at a significantly higher rate in the silodosin group (73.9%) and combination group (84%) compared to the mira …
Comparative Study between Silodosin and Tamsulosin in Expectant Therapy of Distal Ureteral Stones.
Gharib T, Mohey A, Fathi A, Alhefnawy M, Alazaby H, Eldakhakhny A. Gharib T, et al. Urol Int. 2018;101(2):161-166. doi: 10.1159/000490623. Epub 2018 Jul 19. Urol Int. 2018. PMID: 30025399 Clinical Trial.
OBJECTIVE: To compare the efficacy and safety of silodosin against tamsulosin as medical expulsion therapeutic agent in stone lower 1/3rd ureter. ...The adverse effects were comparable with non-significant more retrograde ejaculation in the silodosin group. CONCLUSI …
OBJECTIVE: To compare the efficacy and safety of silodosin against tamsulosin as medical expulsion therapeutic agent in stone lower 1 …
83 results